The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women: Results From the Women's Health Initiative
Open accessAbstract
BACKGROUND: Proton pump inhibitor (PPI) medications have been inconsistently shown to be associated with osteoporotic fractures. We examined the association of PPI use with bone outcomes (fracture, bone mineral density [BMD]). METHODS: This prospective analysis included 161 806 postmenopausal women 50 to 79 years old, without history of hip fracture, enrolled in the Women's Health Initiative (WHI) Observational Study and Clinical Trials with a mean (SD) follow-up of 7.8 (1.6) years. Analyses were conducted for 130 487 women with complete information. Medication information was taken directly from drug containers during in-person interviews (baseline, year 3). The main outcome measures were self-reported fractures (hip [adjudicated], clinical spine, forearm or wrist, and total fractures) and for a subsample (3 densitometry sites), 3-year change in BMD. RESULTS: During 1 005 126 person-years of follow-up, 1500 hip fractures, 4881 forearm or wrist fractures, 2315 clinical spine fractures, and 21 247 total fractures occurred. The multivariate-adjusted hazard ratios for current PPI use were 1.00 (95% confidence interval [CI], 0.71-1.40) for hip fracture, 1.47 (95% CI, 1.18-1.82) for clinical spine fracture, 1.26 (95% CI, 1.05-1.51) for forearm or wrist fracture, and 1.25 (95% CI, 1.15-1.36) for total fractures. The BMD measurements did not vary between PPI users and nonusers at baseline. Use of PPIs was associated with only a marginal effect on 3-year BMD change at the hip (P = .05) but not at other sites. CONCLUSION: Use of PPIs was not associated with hip fractures but was modestly associated with clinical spine, forearm or wrist, and total fractures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
Compendium of Physical Activities: Classification of energy costs of human physical activities
AINSWORTH, B. E., HASKELL, W. L., LEON, A. S., JACOBS, D. R., MONTOYE, H. J., SALLIS, J. F., & PAFFENBARGER, R. S. (1993) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199301000-00011 · Cited by 4,102
Design of the Women’s Health Initiative Clinical Trial and Observational Study
(1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,585
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
Yang, Y.-X., Lewis, J. D., Epstein, S., & Metz, D. C. (2006) · JAMA · doi:10.1001/jama.296.24.2947 · Cited by 1,214
Langer, R. D., White, E., Lewis, C. E., Kotchen, J. M., Hendrix, S. L., & Trevisan, M. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00047-4 · Cited by 630
Use of proton pump inhibitors and risk of osteoporosis-related fractures
Targownik, L. E., Lix, L. M., Metge, C. J., Prior, H. J., Leung, S., & Leslie, W. D. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071330 · Cited by 436
O’Connell, M. B., Madden, D. M., Murray, A. M., Heaney, R. P., & Kerzner, L. J. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.007 · Cited by 405
Kristal, A. R., Feng, Z., Coates, R. J., Oberman, A., & George, V. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009203 · Cited by 298
Factors Associated With 5-Year Risk of Hip Fracture in Postmenopausal Women
Robbins, J., Aragaki, A. K., Kooperberg, C., Watts, N., Wactawski-Wende, J., Jackson, R. D., LeBoff, M. S., Lewis, C. E., Chen, Z., Stefanick, M. L., et al. (2007) · JAMA · doi:10.1001/jama.298.20.2389 · Cited by 246
Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans
Mizunashi, K., Furukawa, Y., Katano, K., & Abe, K. (1993) · Calcified Tissue International · doi:10.1007/bf01352010 · Cited by 238
Cited by
Clinical Practice Guideline: Hoarseness (Dysphonia) (Update)
Stachler, R. J., Francis, D. O., Schwartz, S. R., Damask, C. C., Digoy, G. P., Krouse, H. J., McCoy, S. J., Ouellette, D. R., Patel, R. R., Reavis, C. (. W., et al. (2018) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599817751030 · Cited by 368
MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management
Mirza, F., & Canalis, E. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0118 · Cited by 331
Overutilization of proton-pump inhibitors: what the clinician needs to know
Heidelbaugh, J. J., Kim, A. H., Chang, R., & Walker, P. C. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12437358 · Cited by 327
Ito, T., & Jensen, R. T. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0141-0 · Cited by 309
Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11 International Studies
Yu, E. W., Bauer, S. R., Bain, P. A., & Bauer, D. C. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.01.007 · Cited by 295
Metadata
- Authors
- Gray, S. L.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2010-05-10
- Volume
- 170
- Issue
- 9
- Pages
- 765
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2148792541
- Cited by
- 329
- References
- 18
- FWCI
- 40.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women: Results From the Women's Health Initiative. https://app.cochat.ai/papers/10.1001/archinternmed.2010.94
- The paper
- Gray, S. L. (2010). Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women: Results From the Women's Health Initiative. Archives of Internal Medicine. https://doi.org/10.1001/archinternmed.2010.94
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.